ANP32B and leukemia: ANP32B was shown to be important for cell proliferation, apoptosis, and cell cycle progression [14,15], and to participate in various types of cancer, including leukemia [14,16], breast cancer [17,18], hepatocellular carcinoma [19,20], pancreatic adenocarcinoma [21] and thyroid carcinoma [22].